VAERS reports by lot

Merck HPV lot M042853: VAERS reports

47 VAERS reports list lot M042853 as a Merck HPV vaccine, received between 2017-04-12 and 2019-09-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
47
Reports
11%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological2427%
General / Systemic (non-local)1618%
Musculoskeletal1011%
Allergic / Anaphylactic89%
Dermatological (non-injection-site)89%
Cardiac / Cardiovascular78%
Gastrointestinal78%
Injection-site / Local reaction67%
Respiratory33%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas10
Virginia5
New York4
Pennsylvania3
Massachusetts3
Illinois3
Puerto Rico3
Kentucky2
Arizona1
Georgia1
Oklahoma1
South Carolina1

Reports by month received

2017-042
2017-053
2017-065
2017-079
2017-0818
2017-095
2017-101
2018-041
2019-071
2019-081
2019-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.